Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Scanfil Q3'26 preview: Pace of growth and earnings growth have remained high

SCANFLAnalyst Comment2026-10-19 08:43
Antti ViljakainenHead of Research
Discuss

Summary

  • Scanfil's Q3 revenue is expected to grow by nearly 26% year-on-year to 241 MEUR, driven primarily by the MB and ADCO acquisitions and moderate organic growth.
  • Adjusted EBITA is forecasted to increase by 26% to 17.7 MEUR, with the EBITA margin remaining stable at 7.4%, supported by increased capacity utilization and favorable margins from acquisitions.
  • Despite inflationary pressures, Scanfil's reported EPS is expected to rise to EUR 0.17, reflecting improved operating profit, though higher PPA depreciation and financial expenses weigh on earnings.
  • Scanfil is anticipated to reiterate its 2026 guidance, with revenue projected between 940-1,060 MEUR and adjusted EBITA between 64-78 MEUR, amid a positive demand environment despite macroeconomic uncertainties.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Translation: Original published in Finnish on 10/19/2026 at 8:00 am EEST.

EstimatesQ3'25Q3'26Q3'26eQ3'26e2026e
MEUR/EURComparisonActualizedInderesConsensusInderes
Revenue191.3 240.7 1003.5
EBITA (adj.)14.1 17.7 72.4
EBIT12.6 16.7 67.6
Profit before tax12 15.2 61.8
EPS (reported)0.14 0.17 0.7
Revenue growth-%10.40% 25.80% 25.90%
EBITA-% (adj.)7.40% 7.40% 7.20%

Source: Inderes

Scanfil will publish its Q3 report on Friday, October 23, at 8:00 am EEST. We expect the company's revenue to have continued its strong growth path from the beginning of the year, particularly due to the MB and ADCO acquisitions, as well as moderate organic growth. Although we expect the operational result to have improved significantly due to acquisitions and increased volume, our Q3 profitability estimate remains stable in an increasingly inflationary business environment. The company recently reiterated its guidance for the current year in connection with its Capital Markets Day, and we expect the guidance to remain unchanged in the Q3 report as well. In our view, Scanfil's share is tolerably priced relative to its positive growth and earnings growth outlook (2027e: adj.  EV/EBIT 12x), so we are not making any changes to our view on the company at this time.

Revenue to continue on a strong growth trajectory, driven especially by acquisitions

We forecast Scanfil's Q3 revenue to have grown by almost 26% year-on-year to 241 MEUR (Q3’25: 191 MEUR). As in previous quarters, the clear main driver of growth is inorganic, as the MB and ADCO acquisitions, which were integrated earlier in the year, provide significant support to the top line. However, we also expect organic growth to have continued at a moderate level of around 7–8%, some of which consists of price increases implemented to offset cost pressures. We estimate that all regions grew organically at roughly the same pace, but reported growth is weighted toward the Americas and Central Europe due to acquisitions. We believe demand has been supported by the ramp-up of new customer projects and exceptionally strong momentum in the Aerospace & Defense segment. We expect underlying demand in Medtech & Life Science and Energy & Cleantech to have remained favorable, while macroeconomic uncertainties in the Industrial segment have likely weighed on organic volume growth.

Operating profit has increased with volumes

We expect Scanfil's adjusted EBITA to have grown by 26% in Q3 to 17.7 MEUR, driven by all segments. In our estimation, earnings growth has primarily been driven by strong revenue growth, while we forecast that the adjusted EBITA margin has remained at the level of the comparison period, 7.4%. We estimate that relative profitability has been supported by increased capacity utilization and the margin profile of the acquired companies, which is fundamentally slightly better than Scanfil's average. Conversely, the upside for margins remains limited by an increasingly inflationary operating environment (cf. the rise in the prices of memory and energy-intensive raw materials, in particular). On the bottom line, earnings are weighed down by higher PPA depreciation resulting from acquisitions, as well as increased financial expenses and a slightly higher tax rate from the acquisitions. Thus, we forecast Scanfil's reported earnings per share to have risen to EUR 0.17, reflecting the operating profit. We estimate that Scanfil's cash flow recovered somewhat seasonally in Q3 from the weak beginning of the year, but despite the company's efficiency measures, inflation is likely to create upward pressure at least on the absolute level of working capital year-on-year.

Guidance repetition is the baseline scenario, with focus on the demand environment

In connection with its Capital Market Day at the end of September, Scanfil reiterated its guidance for the current year according to which 2026 revenue will be 940-1,060 MEUR and adjusted EBITA 64-78 MEUR. We expect the company to reiterate this guidance also in conjunction with the Q3 report. Our full-year estimates are solidly in the middle of the ranges.

We will follow with particular interest the company's comments in the report on customer demand outlooks amid prevailing macroeconomic and geopolitical uncertainty and an increasingly inflationary economic environment. The strong momentum in the defense sector, previous project wins, and continued good new sales provide an important buffer for the company, in our view, and the near-term outlook is somewhat upbeat despite the uncertainties. We also expect the company to be able to raise its prices with relatively little delay compared to inflation of raw materials and components, so, provided that the positive demand environment continues, the impact of inflation on Scanfil's absolute earnings will be limited, in our view.

Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.

Read more on company page

Key Estimate Figures01/10

202526e27e
Revenue797.11,003.51,084.6
growth-%2.2 %25.9 %8.1 %
EBIT (adj.)56.472.481.2
EBIT-% (adj.)7.1 %7.2 %7.5 %
EPS (adj.)0.650.760.90
Dividend0.250.260.27
Dividend %2.5 %2.0 %2.1 %
P/E (adj.)15.417.114.4
EV/EBITDA8.59.89.1

Forum discussions

Here are Antti’s preview comments as Scanfil reports its Q3 results this Friday :)\n\n> We expect the company’s revenue to have continued on...
10 hours ago
by Sijoittaja-alokas
1
Antti has published a new company report inspired by the capital markets :)\n\n> We raise our target price for Scanfil to EUR 14.00 (previously...
10/1/2026, 5:23 AM
by Sijoittaja-alokas
5
Here are Mr. Viljakainen’s comments on Scanfil’s announcement regarding its new targets. On Tuesday, Scanfil announced that it is raising its...
9/30/2026, 5:19 AM
by Sijoittaja-alokas
4
Thanks for all the comments. Strategy and financial targets fall under the board’s authority, but as a rule, the board does not comment on them...
9/29/2026, 8:48 AM
by Pasi Hiedanpää
14
Yes, releases must state if the company’s board of directors has made a decision. Or at least the release should be signed by the board. Otherwise...
9/29/2026, 8:28 AM
by Palle
0
What makes you conclude that this is the case? The press release certainly includes the CEO’s comments and contact information, but that doesn...
9/29/2026, 7:16 AM
by Kanye_Cash
1
Is the board at Scanfil merely a rubber stamp, given that the company’s long-term targets are set by the CEO and not the board? Pretty strange...
9/29/2026, 6:25 AM
by Palle
0